Task: Answer the multiple-choice question.
Query: Which drug exhibits a 23.501% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) COC(=O)c1ccc[n+](CC(=O)c2ccc(Br)cc2)c1.[Cl-]
(b) C=CCN(c1ccccc1C(=O)O)S(=O)(=O)/C=C/c1ccccc1
Answer: b. C=CCN(c1ccccc1C(=O)O)S(=O)(=O)/C=C/c1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCN(c1ccccc1C(=O)O)S(=O)(=O)/C=C/c1ccccc1
C=CCN(c1ccccc1C(=O)O)S(=O)(=O)/C=C/c1ccccc1
2-[[(E)-2-phenylethenyl]sulfonyl-prop-2-enylamino]benzoic acid